by Manmohan Singh
Vaccine Adjuvants and Delivery Systems brings scientists up to date on recent advances and provides the information they need to select candidate adjuvants.
Vaccine Adjuvants and Delivery Systems:
- Provides a comprehensive overview of the rapidly evolving field and developing formulation methods
- Covers cutting-edge technologies and gives the current status of adjuvants in clinical trails and those still in the pre-clinical stage
- Includes detailed information on specific vaccine adjuvans, including MF59, TLR4 agonists, new iscoms, cytokines, polyphosphazenes, and more
- Provides a historical perspective on the development of vaccine adjuvants and discusses the mechanisms of adjuvant actions
- Covers some novel adjuvants and delivery systems and the safety evaluation of adjuvants
Contents
- Development of vaccine adjuvants - a historical perspective
- Antigen-Processing and Presentation
- Mechanisms of Adjuvant Action
- Aluminum-containing Adjuvants: Properties, Formulation and Use
- MF59: A Safe and Potent Oil in Water Emulsion Adjuvant
- TLR4 agonists as vaccine adjuvants
- Immunostimulatory CpG Oligodeoxynucleotides as Vaccine Adjuvants
- Small Molecule Immunopotentiators as Vaccine Adjuvants
- New ISCOMs Meet Unsettled Vaccine Demands
- Surface Charged Poly(lactide-co-glycolide) Microparticles as Novel Antigen Delivery Systems
- Liposomal Cytokines and Liposomes Targeted to Costimulatory Molecules as Adjuvants for HIV Subunit Vaccines
- Archaeosomes Vaccine Adjuvants for Cross-priming CD8+ T Cell Immunity
- Mucosal Adjuvants and Delivery Systems
- Cytokines as Vaccine Adjuvants
- Polyphosphazenes as vaccine adjuvants
- Vaccine Delivery by Transdermal Electroporation
- Nonclinical Safety Assessment of Vaccines, and the Evaluation of Novel Adjuvants and Delivery Systems
- Safety Evaluation of Vaccine Adjuvants
Index